Verteporfin inhibits growth of human glioma in vitro without light activation
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Verteporfin inhibits growth of human glioma in vitro without light activation
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-08-02
DOI
10.1038/s41598-017-07632-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Verteporfin-induced formation of protein cross-linked oligomers and high molecular weight complexes is mediated by light and leads to cell toxicity
- (2017) Eleni K. Konstantinou et al. Scientific Reports
- Neurofibromatosis 2 (NF2) controls the invasiveness of glioblastoma through YAP-dependent expression of CYR61/CCN1 and miR-296-3p
- (2016) Hong Lee et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis
- (2016) Yong Feng et al. OncoTargets and Therapy
- Malignant optic glioma – the spectrum of disease in a case series
- (2015) Ghislaine L. Traber et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness
- (2015) Nicholas Artinian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer
- (2015) Zhongwu Li et al. Molecular Oncology
- Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1
- (2015) Huabing Zhang et al. Science Signaling
- Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1
- (2015) Huabing Zhang et al. Science Signaling
- The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation
- (2014) Katarzyna Brodowska et al. EXPERIMENTAL EYE RESEARCH
- TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells
- (2014) M Bartucci et al. ONCOGENE
- Induction of Covalently Crosslinked p62 Oligomers with Reduced Binding to Polyubiquitinated Proteins by the Autophagy Inhibitor Verteporfin
- (2014) Elizabeth Donohue et al. PLoS One
- Optic nerve glioma: an update
- (2014) Akshay Gopinathan Nair et al. INTERNATIONAL OPHTHALMOLOGY
- Axl and prostasin are biomarkers for prognosis of ovarian adenocarcinoma
- (2013) Pu-xiang Chen et al. Annals of Diagnostic Pathology
- Emerging roles of TEAD transcription factors and its coactivators in cancers
- (2013) Ajaybabu V. Pobbati et al. CANCER BIOLOGY & THERAPY
- Differentiating mTOR inhibitors in renal cell carcinoma
- (2013) Sumanta K. Pal et al. CANCER TREATMENT REVIEWS
- Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer
- (2013) Kamal S. Saini et al. CANCER TREATMENT REVIEWS
- Treat cancers by targeting survivin: Just a dream or future reality?
- (2013) Mohane Selvaraj Coumar et al. CANCER TREATMENT REVIEWS
- Colon Cancer Cells Escape 5FU Chemotherapy-Induced Cell Death by Entering Stemness and Quiescence Associated with the c-Yes/YAP Axis
- (2013) Y. Touil et al. CLINICAL CANCER RESEARCH
- Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma
- (2013) Florian Ewald et al. INTERNATIONAL JOURNAL OF CANCER
- SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma
- (2013) B Mao et al. ONCOGENE
- Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs)
- (2012) J.-S. Mo et al. GENES & DEVELOPMENT
- Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
- (2012) Y. Liu-Chittenden et al. GENES & DEVELOPMENT
- Primary brain tumours in adults
- (2012) Damien Ricard et al. LANCET
- YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29
- (2012) Karen Tumaneng et al. NATURE CELL BIOLOGY
- The p44/wdr77-dependent cellular proliferation process during lung development is reactivated in lung cancer
- (2012) Z Gu et al. ONCOGENE
- Genetics of adult glioma
- (2012) McKinsey L. Goodenberger et al. Cancer Genetics
- Photodynamic therapy of cancer: An update
- (2011) Patrizia Agostinis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CYR61 controls p53 and NF-κB expression through PI3K/Akt/mTOR pathways in carboplatin-induced ovarian cancer cells
- (2011) Kwang-Beom Lee et al. CANCER LETTERS
- Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional Targets Cyr61 and CTGF
- (2011) D. Lai et al. CANCER RESEARCH
- The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
- (2011) Michelangelo Cordenonsi et al. CELL
- Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation
- (2011) A Fernandez-L et al. ONCOGENE
- Methods in Mammalian Autophagy Research
- (2010) Noboru Mizushima et al. CELL
- IRF2BP2 is a skeletal and cardiac muscle-enriched ischemia-inducible activator of VEGFA expression
- (2010) Allen C. T. Teng et al. FASEB JOURNAL
- The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation
- (2010) I. Lian et al. GENES & DEVELOPMENT
- Inhibition of Autophagosome Formation by the Benzoporphyrin Derivative Verteporfin
- (2010) Elizabeth Donohue et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma
- (2010) M Z Xu et al. ONCOGENE
- Oct4 is expressed in human gliomas and promotes colony formation in glioma cells
- (2008) Zhanhui Du et al. GLIA
- Expression of Yes-associated protein in common solid tumors
- (2008) Angela A. Steinhardt et al. HUMAN PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search